arrow
J

Jim Zheng

drug metabolism, gilead sciences, inc., 333 lakeside dr., foster city, california 94404, united states
H指数:15
被引数:1,794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis

Lenacapavir的发现:首个每半年给药一次的衣壳抑制剂,用于HIV-1治疗和暴露前预防

2025-10-010
OAAI
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayS
2024-10-010
OAAI
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV
2023-09-013
OAAI
Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
2020-11-2761
OAAI
Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
2020-05-1458
PREAI
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model
2019-09-09105
OAAI
An advanced BLT-humanized mouse model for extended HIV-1 cure studies
AIDS
IF3.1
2018-01-0248
OAAI
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy
2016-03-0130
OAAI
BASIC AND TRANSLATIONAL-LIVER

基础和翻译-肝脏

2013-06-01329
OA